JLE

Epileptic Disorders

MENU

Cumulative effects of antiseizure medication on intelligence in children with focal epilepsy Volume 24, numéro 5, October 2022

  • [1.] Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012; 129(2): 256-64.
  • [2.] Åndell E, Tomson T, Carlsson S, Hellebro E, Andersson T, Adelöw C, et al. The incidence of unprovoked seizures and occurrence of neurodevelopmental comorbidities in children at the time of their first epileptic seizure and during the subsequent six months. Epilepsy Res 2015; 113: 140-50.
  • [3.] Reilly C, Atkinson P, Das KB, Chin RFM, Aylett SE, Burch V, et al. Cognition in school-aged children with “active” epilepsy: a population-based study. J Clin Exp Neuropsychol 2015; 37(4): 429-38.
  • [4.] Kim E, Ko T. Cognitive impairment in childhood onset epilepsy: up-to-date information about its causes. Korean J Pediatr 2016; 59(4): 155-64.
  • [5.] Braun KPJ. Preventing cognitive impairment in children with epilepsy. Curr Opin Neurol 2017; 30(2): 140-7.
  • [6.] Aldenkamp A, Besag F, Gobbi G, Caplan R, Dunn DW, Sillanpää M. Psychiatric and behavioural disorders in children with epilepsy (ILAE task force report): adverse cognitive and behavioural effects of antiepileptic drugs in children. Epileptic Disord 2016; 18: s55-67.
  • [7.] Lagae L. The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents. Acta Neurol Belg 2017; 117(2): 425-32.
  • [8.] Lagae L. Cognitive side effects of anti-epileptic drugs. The relevance in childhood epilepsy. Seizure 2006; 15: 235-41.
  • [9.] Bath KG, Scharfman HE. Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research. Epilepsy Behav 2013; 26(3): 427-39.
  • [10.] Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology 2004; 62: 872-7.
  • [11.] Verrotti A, Scaparrotta A, Cofini M, Chiarelli F, Tiboni GM. Developmental neurotoxicity and anticonvulsant drugs: a possible link. Reprod Toxicol 2014; 48: 72-80.
  • [12.] Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994; 271(10): 767-70.
  • [13.] Koch S, Titze K, Zimmermann R, Schröder M, Lehmkuhl U, Rauh H. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 1999; 40(9): 1237-43.
  • [14.] Reinisch J, Sanders S, Mortensen E, Rubin D. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995; 274(19): 1518-25.
  • [15.] Deoni SCL, Dean DC, Remer J, Dirks H, O’Muircheartaigh J. Cortical maturation and myelination in healthy toddlers and young children. Neuroimage 2015; 115: 147-61.
  • [16.] Webb SJ, Monk CS, Nelson CA. Mechanisms of postnatal neurobiological development: implications for human development. Dev Neuropsychol 2001; 19(2): 147-71.
  • [17.] Farwell J, Jack Lee Y, Hirtz D, Sulzbacher S, Ellenberg J, Nelson K. Phenobarbital for febrile seizures – effects on intelligence and on seizure recurrence. N Engl J Med 1990; 322: 364-9.
  • [18.] Sulzbacher S, Farwell J, Temkin N, Lu AS, Hirtz DG. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila) 1999; 38(7): 387-94.
  • [19.] Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55(4): 475-82.
  • [20.] Fisher R, Cross JH, French JA, Higurachi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the ILAE – position paper of the ILAE commission for classification and terminology. Epilepsia 2017; 58(4): 522-30.
  • [21.] Vân Phan T, Smeets D, Talcott JB, Vandermosten M. Developmental cognitive neuroscience processing of structural neuroimaging data in young children: bridging the gap between current practice and state-of-the-art methods. Dev Cogn Neurosci 2018; 33: 206-23.
  • [22.] Scheffer IE, French J, Hirsch E, Jain S, Mathern GW, Moshé L, et al. Classification of the epilepsies: New concepts for discussion and debate -Special report of the ILAE Classification Task Force of the Commission for Classification and Terminology. Epilepsia Open 2016; 21(1): 37-44.
  • [23.] Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56(10): 1515-23.
  • [24.] Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: neurotechnique automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-55.
  • [25.] Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000; 97(20): 11050-5.
  • [26.] Desikan RS, Se F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006; 31: 968-80.
  • [27.] Whelan CD, Altmann A, Botia JA, Jahanshad N, Hibar DP, Absil J, et al. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain 2018; 141: 391-408.
  • [28.] Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51(6): 1173-82.
  • [29.] Bennett KH, Pujar SS, Martinos MM, Clark CA, Yoong M, Scott R, et al. Subcortical nuclei volumes are associated with cognition in children post-convulsive status epilepticus: result at nine years follow-up. Epilepsy Behav 2020; 110: 107119.
  • [30.] Woodfield J. The association of structural brain networks with cognition in suspected epilepsy and epilepsy surgery. Univeristy of Edinburg, 2020.
  • [31.] Kaindl AM, Asimiadou S, Manthey D, Turski L, Ikonomidou C. Antiepileptic drugs and the developing brain. Cell Mol Life Sci 2006; 63: 399-413.
  • [32.] Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002; 99(23): 15089-94.
  • [33.] Emerit M, Riad M, Hamon M. Trophic effects of neurotransmitters during brain maturation. Biol Neonate 1992; 62(4): 193-201.
  • [34.] Retz W, Kornhuber J, Riederer P. Neurotransmission and the ontogeny of human brain. J Neural Trans 1996; 103: 403-19.
  • [35.] Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH. New evidence for neurotransmitter influences on brain development. Trends Neurosci 1997; 20(6): 269-74.
  • [36.] Nguyen L, Rigo J, Rocher V, Belachew S, Malgrange B, Rogister B, et al. Neurotransmitters as early signals for central nervous system development. Cell Tissue Res 2001; 205: 187-202.
  • [37.] Nederlandse Vereniging voor N. Richtlijnen epilepsie: neuropsychologisch onderzoek. 2015. http://epilepsie.neurologie.nl/cmssite/index.php?pageid=324